Acquisition Opportunity Recent acquisition of NeuroTrials Research by Conquest Research LLC (a portfolio company of Reynolda Equity Partners) suggests potential for strategic realignment, cross-sell of services, and integration with larger clinical trial networks in pursuit of scale and expanded capabilities.

Local Access Advantage Located in Atlanta with proximity to major hospital systems and MARTA, NeuroTrials offers convenient access for site-facing partnerships, community outreach programs, and expedited patient recruitment for regional and national studies.

Clinical Expertise Established track record with nationally sponsored clinical trials and a decade of physician/research leadership position NeuroTrials as a credible partner for sponsor organizations seeking high-quality data and compliant study execution.

Mid-Sized Footprint Employee range of 11-50 and revenue in the 1M–10M band indicate a nimble, boutique CRO profile with opportunities to upsell specialized services (e.g., late-phase support, site management, specialized protocols) to mid-market sponsors.

Digital & Compliance Readiness Tech stack and adherence to international research standards highlight readiness for streamlined trial operations, data capture, and regulatory compliance, enabling scalable collaboration with larger sponsors seeking reliable trial partners.